The end of the beginning: circulating tumor cells as a biomarker in castration-resistant prostate cancer

J Clin Oncol. 2014 Apr 10;32(11):1104-6. doi: 10.1200/JCO.2013.54.7307. Epub 2014 Mar 10.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Atrasentan
  • Docetaxel
  • Humans
  • Male
  • Neoplastic Cells, Circulating*
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / pathology*
  • Pyrrolidines / therapeutic use*
  • Taxoids / therapeutic use*

Substances

  • Antineoplastic Agents
  • Pyrrolidines
  • Taxoids
  • Docetaxel
  • Atrasentan